Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-005600

INTERIM CFO bought 50,000 shares at $0.72 ($36,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Geffken Daniel E. INTERIM CFO 2021-11-29 Purchase +50,000 $0.72 $36,000 50,000 D: show line 1 in the form
Open-market purchases · 50,000 sh · avg $0.72 · $36,000
Loading xslF345X03/form4-12012021_081251.xml…